Weill Cornell Medicine-Cutaneous Oncology and Melanoma Program

Samuel H. Selesnick, M.D., F.A.C.S. is Professor and Vice Chair of the Department of Otolaryngology and Professor of Otolaryngology in Neurological Surgery at the Weill Cornell Medical College, and is a member of the Department of Neurological Surgery at Memorial Sloan Kettering Cancer Center.Dr. Selesnick is the Editor-in-Chief of The Laryngoscope, which is the oldest and largest otolaryngology peer reviewed journal.Dr. Selesnick is aPast President of the American Otological Society andis a Past President of the American Neurotology Society, the largest specialty organization of neurotologists - skull base surgeons in the United States.Dr. Selesnick is the General Secretary of the International Society for Otology (The Politzer Society).Neurotology encompasses lateral skull base surgery for tumors such as vestibular schwanommas (acoustic neuromas), meningiomas,epidermoid tumors and glomus tumors, as well as the surgical and medical treatment for patients suffering from complex ear-related problems such as hearing loss, otosclerosis, cholesteatoma and facial nerve tumors.Dr. Selesnick has lectured on neurotologic and ear related topics in the United States, France, Italy, the United Kingdom, Austria, Denmark, Spain, the Czech Republic, Croatia, Greece, Poland, Australia, Japan, Israel, the United Arab Emirates, Qatar, India, the Ukraine, Canada, Brazil and MexicoDr. Selesnick has received The Certificate of Honor bestowed by The American Academy of Otolaryngology-Head and Neck Surgery, and has been named one of the best doctors in his field by lay publications. Dr. Selesnick sits on the editorial board of the journal 'Otology and Neurotology' and has served as guest editor of 'The Otolaryngologic Clinics of North America'. Dr. Selesnick has served on the Executive Council of The American Neurotology Society, and has served on or chaired numerous committees for the American Academy of Otolaryngology-Head and Neck Surgery, The American Otological Society, The Triological Society, The American College of Surgeons and other medical societies. Dr. Selesnick serves on the Board of Directors of the American Academy of Otolaryngology - Head and Neck Surgery.Dr. Selesnick has researched topics in neurotology - skull base surgery and otology, and has published extensively in peer reviewed journals. The second book he has co-edited was released in November 2010.At the NewYork-Presbyterian Hospital/Weill Cornell Medical Center, Dr. Selesnick has pioneered skull base surgery for acoustic neuromas and meningiomas as well as other skull base lesions. He has pioneered the use of lasers for the treatment of hearing loss in otosclerosis, and for the treatment of cholesteatoma, during mastoidectomy surgery and for tympanoplasty to repair tympanic membrane perforation.Dr. Selesnick received a Bachelor of Arts from Wesleyan University and graduated from the New York University School of Medicine. He completed his training in Otolaryngology at The Manhattan Eye, Ear, and Throat Hospital - Cornell Residency Program and went on to advanced Fellowship training in Otology, Neurotology, and Skull Base Surgery at The University of California, San Francisco. Dr. Selesnick has been frequently interviewed by the television, radio, and print media. He is an Honorary Police Surgeon in the New York Police Department.His website address is http://www.weillcornell.org/physician/samuelselesnick/index.html."The Acoustic Neuroma Association would like to thank the Weill Cornell Medicine Department of Neurological Surgery for partnering with the ANA as a Gold sponsor."To learn more about ANA please click the below link:https://www.anausa.org

Dr. Kisss training began in New York City where he received his undergraduate degree with honors from Columbia College and medical school training at Columbia University College of Physicians & Surgeons. He then moved to Boston to complete his ophthalmology residency and surgical vitreoretinal fellowship, both at Harvard Medical School and the Massachusetts Eye & Ear Infirmary. At Harvard, Dr. Kiss was select by the faculty to serve as the Chief Retina Fellow. Dr. Kiss was then recruited back to New York City to join the vitreoretinal faculty at Weill Cornell Medical College and assume the role of Director of Clinical Research in the Department of Ophthalmology.Dr. Kiss's clinical interests include complex vitreoretinal surgery and treatment of age?related macular degeneration and diabetic retinopathy. His clinical and translational research focuses on four broad areas: retinal imaging, ocular gene therapy, novel therapeutic targets for ocular neovascularization, and genetic markers for retinal diseases. Dr. Kiss has participated as a principal investigator in over two-dozen prospective clinical trials and laboratory investigations. He has authored over 200 scientific publications, given over 100 invited lectureships worldwide, and serves on the Editorial Board and as a Scientific Reviewer to a number of major journals. Dr. Kiss has won numerous academic and scientific awards including the Heed Ophthalmic Foundation Fellowship, the Ronald G. Michels Foundation Fellowship, the Paul Kayser International Fellowship, and the Research to Prevent Blindness Physician-Scientists Award. Dr. Kiss has been named to several regional and national Top Doctors lists, includingThe Ophthalmologistworldwide Top 40 Under 40, Castle Connollys Top Doctors in America, andNew York Super Doctors Rising Stars.

Rutika Mehta MD, MPH is an Associate Professor in Medicine and Attending Physician at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Mehta received her medical degree at Topiwala National Medical College in Mumbai, India. She subsequently completed a Masters in Public Health with a focus on Epidemiology at Indiana University, Indianapolis. She spent three years as a Research Fellow in the Department of Pathology at Indiana University School of Medicine. She then completed her training in Internal Medicine at Johns Hopkins University/Sinai Hospital of Baltimore followed by a fellowship in Hematology/Oncology at Roswell Park Comprehensive Cancer Institute in Buffalo, New York. After completing her hematology and oncology training, Dr. Mehta joined the gastrointestinal (GI) oncology department at the H. Lee Moffitt Cancer Center in Tampa, Florida. At Moffit Cancer Center, Dr. Mehta worked with many renowned leaders in the field and was instrumental in building the clinical and research program for upper GI malignancies. She was selected as a Castle Connolly “Top Doctor” for three straight years in the Tampa Bay area (2022-2024). Additionally, Dr. Mehta has had experience leading several clinical trials for GI cancer patients and has developed some novel trials herself. She is an active member of the American Society of Clinical Oncology (ASCO) and serves as a member of the National Cancer Institute (NCI) Taskforce for Esophagogastric Cancers. Dr. Mehta was recruited to Weill Cornell Medicine (WCM) in 2024. Her clinical and research efforts will focus on all GI cancers with a particular emphasis on developing clinical trials utilizing novel treatment options and advancing the field through precision medicine.